Prenatal cannabis exposure linked to heightened risk of ADHD symptoms

A recent meta-analytic study has explored the connection between maternal cannabis use during pregnancy and the occurrence of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) symptoms in their children. The researchers found that children whose mothers used cannabis during pregnancy were more likely to have symptoms of ADHD compared to children whose…

Read More

Do ADHD Meds Lead to Addiction?

It’s an important issue for parents whether the use of stimulant medications like Adderall to treat ADHD in children puts those children at risk for later substance abuse.

Read More

Navigating the current shortages of pediatric ADHD medications

[Excerpt] The initial shortage of dextroamphetamine/amphetamine caused a subsequent increased demand for methylphenidate, which led to its own respective shortage in response.3 An additional reason for these shortages could be a lack of available active ingredients to manufacture the medications.4 This article will continue to discuss medications that are currently available as of January 2024…

Read More

Starting ADHD Medications May Lower Death Risk

For patients with attention-deficit/hyperactivity disorder (ADHD), starting medication was associated with a significantly lower risk of death, particularly from “unnatural” causes, according to an observational Swedish study. Among nearly 150,000 Swedish patients with ADHD, medication initiation was associated with a significantly lower rate of all-cause mortality over 2 years (HR 0.79, 95% CI 0.70-0.88) compared…

Read More

ADHD: The Power of Community

Got ADHD? Do you yearn to be understood? Do you need a safe place to go—just to process, connect, and to be with your tribe? In this episode of Attention Talk Radio, ADHD and attention coach Jeff Copper (https://digcoaching.com) interviews René Brooks (https://blackgirllostkeys.com). The two discuss the power of community, the challenge of finding community,…

Read More

No End in Sight for National ADHD Drug Shortage

Nearly 18 months after the US Food and Drug Administration (FDA) first acknowledged a national shortage of Adderall, the most common drug used to treat attention-deficit/hyperactivity disorder (ADHD), there is now a widespread scarcity of other stimulant medications — with no end in sight. How did this crisis develop and what measures are underway to…

Read More

ADHD Research Roundup: March 1, 2024

In this Research Roundup, we explore new studies on attention-deficit/hyperactivity disorder (ADHD) and its potential connections to risk of mortality, unintentional injuries, and experiences of intimate partner violence.

Read More